Perrigo (PRGO) stock is in focus after the company reported a sharply higher first quarter net loss, driven by a US$330.8 million goodwill impairment charge, and reaffirmed guidance for full year net sales to decline.

The earnings miss, goodwill impairment and reaffirmed outlook for lower net sales have coincided with clear selling pressure, with the share price down 10.1% over the past month and the 1 year total shareholder return declining 58.6%, pointing to fading momentum.

If this kind of reset in sentiment has you looking around the market for other ideas, it may be worth scanning 29 healthcare AI stocks to find different health focused opportunities tied to AI trends.

With Perrigo trading at US$10.61, carrying an intrinsic discount flag and sitting well below analyst price targets, the key question is whether recent losses are already fully reflected in the stock or if the market is overlooking any potential for recovery.

Most Popular Narrative: 35.7% Undervalued

With Perrigo closing at $10.61 against a narrative fair value of $16.50, the spread between price and story is wide enough to examine closely.

Recent new business wins in US store-brand OTC have outpaced distribution losses for the first time since the 2024 reset, with net new contract gains expected to add $75M+ to sales in the second half, directly supporting a step-change in revenue growth and operating income.

Want to see how flat top line assumptions can still support a higher valuation? The narrative leans heavily on margin repair and a richer future profit multiple. Curious which specific earnings and return hurdles underpin that $16.50 figure and the discount rate behind it? The full story connects those pieces in a tight valuation case.

Result: Fair Value of $16.50 (UNDERVALUED)

However, there are clear pressure points, including softer infant nutrition trends and ongoing cost inflation. These factors could cap margin repair and limit how much earnings power improves.

Next Steps

With sentiment pulled sharply in both directions by risks and rewards, this is a moment to move quickly and test the data yourself. Start with 4 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Perrigo has sharpened your thinking, do not stop here. Broaden your watchlist with focused stock ideas filtered by quality, value and resilience.

• Target potential mispricing by scanning companies flagged as quality opportunities in the 54 high quality undervalued stocks.
• Strengthen your defensive core by reviewing companies highlighted in the 66 resilient stocks with low risk scores.
• Get ahead of the crowd by checking companies surfaced by the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.